16 December 2025
Disclaimer: This is a simplified summary of a public company filing. See full disclaimer here.
Resonate Blends, Inc.
CIK: 897078•2 Annual Reports•Latest: 2025-06-10
10-K / June 10, 2025
Revenue:$1,349,905
Income:-$1,555,767
10-K / April 16, 2024
Revenue:$16,468
Income:-$1,415,979
10-K / June 10, 2025
Company Summary: Resonate Blends, Inc.
Business Focus and Operations
- Core Business: Engages in the discovery, development, and marketing of products aimed at improving human health and performance.
- Market Position: Positioning as a leader in the field of Regenerative Medicine, as defined by the NIH, utilizing nutritionally designed products.
- Product Marketing: Aiming to market products under third-party label exemptions.
Key Products and R&D
- Natural Stem Cell Mobilizing Agents: Licensed patent-pending products designed to enhance individuals’ ability to mobilize their own adult stem cells from bone marrow.
- Natural Diet Aids: Licensed under a patent-pending application, these dual-acting all-natural diet aids help control hunger using body signals to the brain and stomach.
- Research Focus: Exploring bioactive formulations such as Secretogues to naturally enhance growth hormone production and human performance without drugs.
Market Segments
- Consumer Market: Products aimed at individual health enhancement.
- Professional Market: Products adapted for use by health professionals.
Customer and Market Data
- Number of Customers: Not explicitly provided.
- Revenue:
- For the nine months ending September 30, 2024, revenue was approximately $1,349,905 (unaudited); all of this was attributable to EMGE (acquired in March 2024).
- For the nine months ending September 30, 2023, revenue was approximately $16,468 (unaudited); attributable to the subsidiary before acquisition.
- Income:
- Net loss for the nine months ending September 30, 2024: $1,555,767 (unaudited).
- Net loss for the same period in 2023: $1,011,432 (unaudited).
Employees
- Staffing: No specific number of employees is provided; management states there are no significant employees.
Additional Details
- Growth and Development: Focused on expanding marketing and R&D in bioactive and performance-enhancing formulations.
- Financials & Market:
- The company is publicly traded on OTCQB under the symbol “KOAN.”
- Stockholders' equity is negative, with a total shareholders’ deficit of approximately $3.2 million as of December 31, 2024.
- The company has a history of incurring losses and has a significant accumulated deficit of over $28 million.
- Has a working capital deficit of approximately $3.5 million as of December 31, 2024.
- Relies on convertible debt, loans, and external financing for operations.
Summary
Resonate Blends, Inc. is a biotech and nutraceutical company involved in developing natural, patent-pending products aimed at stem cell activation and appetite control, targeting health-conscious consumers and professionals. It is active in R&D for performance and growth hormone enhancement, with recent revenue driven mainly by its acquisition of EMGE. The company faces financial challenges, including ongoing losses and a significant deficit, and is in the process of expanding its product offerings and market penetration.
